Dividend Overview
Dividend Yield
—
Dividend / Share
—
Teva- Pharmaceutical Industries Ltd
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.
Current Price
$35.73
-0.78%GoodMoat Value
$21.98
38.5% overvaluedProfile
Valuation (TTM)
Market Cap$41.08B
P/E26.27
EV—
P/B5.19
Shares Out1.15B
P/Sales2.37
Revenue$17.35B
EV/EBITDA16.43
Teva- Pharmaceutical Industries Ltd (TEVA) Dividends
Key Metrics
Market Cap
$41.08B
P/E Ratio
26.27
Forward P/E
—
EPS
$1.21
PEG Ratio
0.38
Book Value
$6.88
Dividend Yield
—
Profit Margin
9.01%
ROE
19.77%
Dividend History
Dividend Safety
TEVA Dividend Analysis
Teva- Pharmaceutical Industries Ltd (TEVA) dividend analysis including yield, payout history, and sustainability metrics.
P/E ratio: 26.27. Profit margin: 9.01%. Free cash flow: $1.15B. This page shows Teva- Pharmaceutical Industries Ltd's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.
GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Teva- Pharmaceutical Industries Ltd's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.